Archive

TOGETHER trial shows positive effect for ivermectin

Written by | 5 Feb 2023

The TOGETHER trial was widely reported as showing that ivermectin was not effective in covid-19, but a straightforward analysis of the results reveals a 59 per cent reduction […]

Ivermectin – is it safe and effective?

Written by | 4 Feb 2023

The best time to administer ivermectin is at the beginning of a covid-19 infection so that virus is killed and disease progression averted, according to Colleen Aldous, Professor […]

What makes the SAIVE study so good?

Written by | 3 Feb 2023

Professor Colleen Aldous is a research professor at the School of Clinical Medicine at the University of Kwazulu-Natal in South Africa. She recently described the SAIVE trial of […]

New research shows pandemic’s toll on frontline healthcare workers

Written by | 28 Jan 2023

For frontline healthcare workers, the mental health impact from the pandemic is extending beyond career burnout.  Much of the attention on the mental toll suffered by frontline workers […]

500,000 missed out on blood pressure lowering drugs during pandemic

Written by | 22 Jan 2023

Nearly half a million people missed out on starting medication to lower their blood pressure during the Covid-19 pandemic, according to research supported by the British Heart Foundation […]

COVID-19 vaccine acceptance increased globally in 2022

Written by | 13 Jan 2023

Global willingness to accept a COVID-19 vaccine increased from 75.2% in 2021 to 79.1% in 2022, according to a new survey of 23 countries that represent more than 60% of […]

Decreased influenza prevalence potentially associated with public health measures against COVID-19

Written by | 1 Jan 2023

A recent study provides preliminary evidence of the long-term relationship between prevention and control measures and influenza transmission in China during the COVID-19 pandemic, accounting for the impact […]

Treating COVID-19 infection with molnupiravir does not decrease deaths or hospital admission in high-risk, vaccinated patients, but can lead to quicker recovery

Written by | 28 Dec 2022

Molnupiravir (taken as an 800mg dose twice daily for five days) does not reduce hospital admissions or deaths in vaccinated adults with COVID-19 infection who are at higher […]

Paxlovid effective in reducing COVID-19 hospitalization among vaccinated adults 50 and over

Written by | 15 Dec 2022

The antiviral drug nirmatrelvir plus ritonavir (Paxlovid) was granted Emergency Use Authorization for treating COVID-19 in December 2021. In clinical trials, the antiviral was associated with an 88% […]

Community pharmacy-led vaccination scheme helped thousands of patients overcome hesitancy around Covid-19 jabs

Written by | 6 Dec 2022

An award-winning scheme that saw community pharmacists support patients to understand the benefits of being jabbed against Covid-19 and overcome initial hesitancy proved hugely successful, new research by […]

Post-COVID syndrome can strike at any age

Written by | 26 Nov 2022

Children, adolescents and adults have recorded significant new illnesses across 13 distinct diagnosis and symptom complexes after infection with COVID-19, according to a new study published in PLOS Medicine by […]

National poll: 1 in 7 parents haven’t discussed vaccines with their child’s primary care provider during pandemic period

Written by | 22 Nov 2022

Parents may not always turn to health professionals for vaccine advice – and a small subset could even be avoiding the conversation – a new national poll suggests. […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.